New $20 million initiative focuses on community-driven health research

A new $20 million research initiative will engage the people most impacted by health disparities in developing solutions that may help improve their overall health and well-being.

BioCryst secures $69m contract from US to supply RAPIVAB for influenza

The injection has been approved in the US to treat simple flu cases in patients as young as six months. Credit: pedro7merino via Shutterstock. BioCryst

October 1, 2024

Texas Hospitals Must Now Ask Patients Whether They Are in the U.S. Legally

Texas hospitals must ask patients starting Friday whether they are in the U.S. legally and track the cost of treating people without legal status following

November 2, 2024

Oxford Biomedica pivots by laying off 200 people, acquiring ABL Europe amid declining total revenues

In its bid to become a pure-play cell and gene therapy CDMO, Oxford Biomedica is laying off 200 staff members in the UK and US,

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.